U.S. markets close in 2 hours 7 minutes

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
63.56+2.23 (+3.63%)
As of 1:53PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 6/20/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 385.01%
S&P500 52-Week Change 333.63%
52 Week High 373.50
52 Week Low 326.17
50-Day Moving Average 357.10
200-Day Moving Average 361.45

Share Statistics

Avg Vol (3 month) 3809.97k
Avg Vol (10 day) 31.43M
Shares Outstanding 5149.28M
Implied Shares Outstanding 6N/A
Float 72.09M
% Held by Insiders 17.49%
% Held by Institutions 195.37%
Shares Short (May 27, 2021) 410.39M
Short Ratio (May 27, 2021) 413.76
Short % of Float (May 27, 2021) 412.71%
Short % of Shares Outstanding (May 27, 2021) 46.96%
Shares Short (prior month Apr 29, 2021) 411.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-6,193.31%

Management Effectiveness

Return on Assets (ttm)-32.37%
Return on Equity (ttm)-1,789.67%

Income Statement

Revenue (ttm)8.71M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)8.25M
Net Income Avi to Common (ttm)-519.95M
Diluted EPS (ttm)-4.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)919.12M
Total Cash Per Share (mrq)6.16
Total Debt (mrq)1.38B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.98
Book Value Per Share (mrq)3.92

Cash Flow Statement

Operating Cash Flow (ttm)-466.56M
Levered Free Cash Flow (ttm)-263.18M